ATP2A2 and muscular dystrophy: In this line,recent studies using mouse models of muscular dystrophies affecting dystrophin–glycoproteincomplex have shown that increasing SERCA activity either by inducing HSP72 expression (Ref.13), or through SERCA1 and SERCA2 overexpressionusing transgenic mice and adeno-associated virus gene therapy (Ref.